How does EndoPredict work?
EndoPredict is a second generation test – this means it is the newest type of test available for predicting breast cancer recurrence.
Second generation tests combine your individual genomic fingerprint with traditional measurements, like tumor size and nodal status, to provide a more accurate assessment of your early and late recurrence risk.
Learn more about how EndoPredict works in our helpful video.